The FDA has approved the monoclonal antibody spesolimab (Spevigo) as the first treatment for generalized pustular psoriasis (GPP), Boehringer Ingelheim announced. The approval stipulates use of the ...
Folliculitis is a common skin condition that occurs when hair follicles become inflamed due to infection, irritation, or blockage. The most frequent cause is a bacterial infection, though fungi and ...
Spevigo is a humanized monoclonal immunoglobulin G1 antibody that inhibits interleukin-36 signaling. The Food and Drug Administration (FDA) has approved Spevigo ® (spesolimab-sbzo) for the treatment ...
The US Food and Drug Administration (FDA) has approved the biologic agent spesolimab (Spevigo) for the treatment of flares in adults with generalized pustular psoriasis (GPP), the company has ...
Cutaneous dental (or odontogenic) sinus tracts are uncommon occurrences in which a channel forms from a dental focus of infection to a drainage site on the skin of the face or neck. Odontogenic sinus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results